Who owns ImmunoGen?

Key details on ImmunoGen (Ticker: IMGN)

Who owns ImmunoGen?

Is IMGN a good stock to own? Find out who bought ImmunoGen, who sold ImmunoGen (IMGN) stock, and who holds a large position in ImmunoGen.

Fund Name Number of Shares Share Valuation As Of
ClearBridge Advisors 14.32M $194.31M Dec. 31, 2015
PRIMECAP Management Company 12.87M $174.61M Dec. 31, 2015
Vanguard 6.39M $86.65M Dec. 31, 2015
OrbiMed Advisors 6.10M $82.72M Dec. 31, 2015
FMR 6.08M $82.46M Dec. 31, 2015
First Trust Advisors 5.81M $61.55M Sept. 30, 2014
Baker Bros. Advisors 4.45M $60.42M Dec. 31, 2015
Sectoral Asset Management 3.22M $38.14M June 30, 2014
BlackRock Fund Advisors 3.13M $42.51M Dec. 31, 2015
Wellington Management Company 3.13M $46.68M March 31, 2014
BB Biotech AG 2.84M $25.43M March 31, 2015
STATE STREET CORPORATION 2.62M $35.55M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 2.43M $21.77M March 31, 2015

Who sold ImmunoGen?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Dec. 31, 2013 2.37M $34.81M